Contract manufacturer Minnetronix has a new med-tech customer: itself
Minnetronix, a 22-year-old medical technology business based in St. Paul, has long specialized as a contract manufacturer — building med-tech devices designed by other firms. It's now growing beyond that role with a new product developed in-house.
The Star Tribune reports on the milestone at Minnetronix, which is working on a device Neurapheresis Therapy that is designed to decontaminate cerebrospinal fluid after a hemorrhagic stroke. The brain needs that fluid clean to function, but the bleeding…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Mark Reilly Source Type: news
More News: Biotechnology | Brain | Contracts | Health Management | Hemorrhagic Stroke | Neurology | Stroke